The document lists 82 product names and their respective dossier statuses. All products have a dossier status of complete technical dossier (CTD), except for Mesalamine Tablets 1.2 g which has a status of dossier can be ready to share by Q2 2022. The products include various drugs across therapeutic areas such as cardiovascular, anti-infective, gastrointestinal, hormonal and thyroid.
The document lists 82 product names and their respective dossier statuses. All products have a dossier status of complete technical dossier (CTD), except for Mesalamine Tablets 1.2 g which has a status of dossier can be ready to share by Q2 2022. The products include various drugs across therapeutic areas such as cardiovascular, anti-infective, gastrointestinal, hormonal and thyroid.
The document lists 82 product names and their respective dossier statuses. All products have a dossier status of complete technical dossier (CTD), except for Mesalamine Tablets 1.2 g which has a status of dossier can be ready to share by Q2 2022. The products include various drugs across therapeutic areas such as cardiovascular, anti-infective, gastrointestinal, hormonal and thyroid.